Yang Ke
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer-related molecular mechanisms research
Papers in
-
- Cancer, Lipids, and Metabolism 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Co-authors
- Lin Wang (12 shared papers)Le‐Qun Li (3 shared papers)Jian‐Hong Zhong (3 shared papers)Haoran Tang (9 shared papers)Yanyan Wang (1 shared paper)Tianhao Bao (8 shared papers)Cheng Zhang (6 shared papers)Xuesong Wu (6 shared papers)
In The Last Decade
Yang Ke
34 papers receiving 655 citations
Peers
Comparison fields: 5 of 81
- Hepatology 158
- Cancer Research 91
- Pharmacology 65
- Pharmacology 29
- Molecular Biology 198
Countries citing papers authored by Yang Ke
This map shows the geographic impact of Yang Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Ke more than expected).
Fields of papers citing papers by Yang Ke
This network shows the impact of papers produced by Yang Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Ke. The network helps show where Yang Ke may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Ke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 97 | |
| 2 | 2016 | 61 | |
| 3 | 2018 | 52 | |
| 4 | 2024 | 49 | |
| 5 | 2019 | 42 | |
| 6 | 2020 | 40 | |
| 7 | 2017 | 32 | |
| 8 | 2022 | 30 | |
| 9 | 2021 | 28 | |
| 10 | 2015 | 23 | |
| 11 | 2021 | 17 | |
| 12 | 2019 | 15 | |
| 13 | 2022 | 14 | |
| 14 | 2019 | 13 | |
| 15 | 2016 | 13 | |
| 16 | 2015 | 13 | |
| 17 | 2019 | 12 | |
| 18 | 2018 | 12 | |
| 19 | 2025 | 11 | |
| 20 | 2020 | 10 |
About Yang Ke
Yang Ke is a scholar working on Cancer Research, Hepatology, Molecular Biology, Biomaterials and Epidemiology, having authored 35 papers that have together received 660 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Nanoparticle-Based Drug Delivery (4 papers), Hepatitis B Virus Studies (2 papers), Polysaccharides and Plant Cell Walls (2 papers), Cancer, Lipids, and Metabolism (2 papers), Medicinal Plant Pharmacodynamics Research (2 papers), Cancer Mechanisms and Therapy (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Hepatology (158 citations), Cancer Research (91 citations), Pharmacology (65 citations), Pharmacology (29 citations) and Molecular Biology (198 citations). Yang Ke has collaborated with scholars based in China, Taiwan and India. Frequent co-authors include Lin Wang, Le‐Qun Li, Jian‐Hong Zhong, Haoran Tang, Yanyan Wang, Tianhao Bao, Cheng Zhang, Xuesong Wu, Yan Wang and Tiangen Wu. Their work appears in journals such as International Journal of Biological Macromolecules, Tumor Biology, International Journal of Pharmaceutics, Journal of Molecular Medicine and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.